Objective To study the efficacy, tolerability, and parental satisfaction of cantharidin in a patient population at a pediatric dermatology referral center.
Methods Chart review was completed for 110 patients who presented with molluscum infection and were treated with cantharidin. A total of 54 were available for follow-up by telephone interview regarding adverse effects, parental satisfaction, and overall clearance of the infection.
Results Of those who were reachable, 96% improved after treatment with cantharidin. Parental satisfaction was 78%. Patients received an average of 2.2 treatments irrespective of outcome. Overall, 46% of patients experienced adverse events, including pain, pruritus, secondary infection, brisk immune response, and temporary hypopigmentation and 9% experienced an adverse event that they classified as severe.
Conclusions The results contribute to the data supporting cantharidin as a safe and effective treatment of molluscum contagiosum. Compared with other treatments, it appears to be equally effective and well-tolerated and should be considered a potential front-line treatment.
Braue A., Ross G., Varigos G., Kelly H.Epidemiology and impact of childhood molluscum contagiosum: a case series and critical review of the literature. Pediatr Dermatol. 2005;22:287-294.
2.
Choong KY, Roberts LJMolluscum contagiosum, swimming and bathing: a clinical analysis. Australas J Dermatol. 1999;40:89-92.
3.
Moed L., Shwadyer TA, Chang MWCantharidin revisited: a blistering defense of an ancient medicine. Arch Dermatol. 2001;137:1357-1360.
4.
Silverberg NB , Sidbury R., Mancini AJChildhood molluscum contagiosum: experience with cantharidin therapy in 300 patients. J Am Acad Dermatol . 2000;43:503-507.
5.
Hanna D., Hatami A., Powell J., et al. A prospective randomized trial comparing the efficacy and adverse effects of four recognized treatments of molluscum contagiosum in children . Pediatr Dermatol. 2006;23:574-579.
